Clinical trials
Phase 2 Mental Disorders trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2018 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 4 |
| Terminated | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 2 |
| Aaron Keshen | 1 |
| Brain and Cognition Discovery Foundation | 1 |
| Centre for Addiction and Mental Health | 1 |
| Inmune Bio, Inc. | 1 |
| MapLight Therapeutics | 1 |
| Nova Scotia Health Authority | 1 |
| Novartis Pharmaceuticals | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
| University Health Network, Toronto | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mental Disorders | 13 |
| Major Depressive Disorder | 5 |
| Alzheimer Disease | 4 |
| Brain Diseases | 4 |
| Central Nervous System Diseases | 4 |
| Dementia | 4 |
| Mood Disorders | 4 |
| Nervous System Diseases | 4 |
| Depressive Disorder, Treatment-Resistant | 3 |
| Depressive Disorder | 2 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.